Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$17.92
1.6910.41%
At close: Jan 7, 4:00 PM EST
$18.05
0.130.73%
After Hours: 7:58 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Alumis (ALMS) stock?
You can purchase shares of Alumis (NASDAQ:ALMS) through any online brokerage.
Who are Alumis (ALMS) competitors?
Other companies in Alumis’s space includes: Atai Beckley NV (NASDAQ:ATAI), Supernus Pharmaceuticals Inc (NASDAQ:SUPN), Rapport Therapeutics Inc (NASDAQ:RAPP), Phibro Animal Health Corp (NASDAQ:PAHC) and ANI Pharmaceuticals Inc (NASDAQ:ANIP).
What is the forecast, or price target, for Alumis (ALMS) stock?
Alumis has a consensus price target of $27.50.
What is the current price for Alumis (ALMS)?
The stock price for Alumis (NASDAQ: ALMS) is $18.05 last updated January 7, 2026 at 7:58 PM EST.
Does Alumis (ALMS) pay a dividend?
There are no upcoming dividends for Alumis.
When is Alumis (NASDAQ:ALMS) reporting earnings?
Alumis does not have any upcoming earnings scheduled.
Is Alumis (ALMS) going to split?
There is no upcoming split for Alumis.
What sector and industry does Alumis (ALMS) operate in?
Alumis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
